Introduction:
The scar reduction and silicone gel sheet market in China has been experiencing significant growth in recent years. With the rise in demand for advanced skincare products and the increasing awareness about scar treatment options, Chinese manufacturers have been stepping up their game to cater to this market. According to recent reports, the market size for scar reduction products in China is estimated to be around $100 million, with an annual growth rate of 8%.
Top 10 Scar Reduction & Silicone Gel Sheet Manufacturers in China:
1. Sinopharm Group Co., Ltd.
Sinopharm Group Co., Ltd. is one of the leading manufacturers of silicone gel sheets in China, with a production volume of over 1 million units per year. The company has established a strong presence in the market with its high-quality products and innovative formulations.
2. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is another key player in the scar reduction market in China, with a market share of 15%. The company’s silicone gel sheets are known for their effectiveness in reducing scars and promoting skin regeneration.
3. Shanghai Fosun Pharmaceutical Group Co., Ltd.
Shanghai Fosun Pharmaceutical Group Co., Ltd. is a major manufacturer of scar reduction products in China, with an annual export value of $10 million. The company’s silicone gel sheets are popular among consumers for their affordable price and excellent results.
4. Jiangsu Hengrui Medicine Co., Ltd.
Jiangsu Hengrui Medicine Co., Ltd. is a renowned manufacturer of silicone gel sheets in China, with a production volume of 500,000 units per year. The company has a strong distribution network across the country, making its products easily accessible to consumers.
5. Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited is a leading manufacturer of scar reduction products in China, with a market share of 12%. The company’s silicone gel sheets are widely used by healthcare professionals for post-operative care and scar management.
6. Hangzhou Minsheng Pharmaceutical Group Co., Ltd.
Hangzhou Minsheng Pharmaceutical Group Co., Ltd. is a well-known manufacturer of silicone gel sheets in China, with an annual production volume of 800,000 units. The company’s products are preferred by consumers for their natural ingredients and gentle formulation.
7. Suzhou Kintor Pharmaceutical Inc.
Suzhou Kintor Pharmaceutical Inc. is a prominent manufacturer of scar reduction products in China, with an export value of $5 million. The company’s silicone gel sheets are highly effective in reducing the appearance of scars and improving skin texture.
8. Zhejiang Hisun Pharmaceutical Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd. is a leading manufacturer of silicone gel sheets in China, with a market share of 10%. The company’s products are known for their advanced technology and superior quality, making them a popular choice among consumers.
9. Beijing SL Pharmaceutical Co., Ltd.
Beijing SL Pharmaceutical Co., Ltd. is a well-established manufacturer of scar reduction products in China, with a production volume of 600,000 units per year. The company’s silicone gel sheets are recommended by dermatologists for their fast-acting formula and long-lasting results.
10. Tasly Pharmaceutical Group Co., Ltd.
Tasly Pharmaceutical Group Co., Ltd. is a reputable manufacturer of silicone gel sheets in China, with an annual export value of $8 million. The company’s products are widely used in hospitals and clinics for scar management and wound healing.
Insights:
The scar reduction and silicone gel sheet market in China is poised for further growth in the coming years, driven by the increasing demand for advanced skincare solutions and the rising awareness about scar treatment options. With the Chinese government’s focus on promoting domestic manufacturing and innovation, local manufacturers are expected to expand their market presence and gain a competitive edge in the global market. According to industry experts, the market size for scar reduction products in China is projected to reach $150 million by 2025, with a CAGR of 10%. This indicates a lucrative opportunity for manufacturers to capitalize on the growing demand for scar treatment solutions in the country.
Related Analysis: View Previous Industry Report
